You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Mass. Mover

Boston Scientific posts loss

Hank Kucheman, CEO of Boston Scientific.

Josh Reynolds/For the Globe/File

Hank Kucheman, CEO of Boston Scientific.

Medical device maker Boston Scientific said it swung to a third-quarter loss, as legal fees and restructuring expenses weighed down already-sluggish sales of the company’s implants. The Natick company adjusted its full-year guidance. It now expects adjusted earnings of 63 to 66 cents per share. Its prior forecast was 62 to 68 cents. For the quarter, it lost $725 million, or 52 cents per share, compared with a profit of $142 million, or 9 cents, a year earlier.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of